Job Title: Group Leader (NGS – Clinical) Reports to: Associate Director FLSA Class: Exempt Introduction to Job Post: The Group Leader role is responsible for managing the detailed research activities of a team of scientists and research associates. The Group ...
Read More »Studies Explore Use of RNA Sequencing in a Clinical Setting to Help Determine Appropriate Treatment
Two studies appearing in the August 23/30 issue of JAMA examine the use of genetic tests to help rule out a serious bacterial infection in infants with fever, and also to determine if an infection is bacterial or viral in ...
Read More »Is Personalized Medicine Here?
Clinical application of next-generation sequencing The widespread availability of genomic analysis of tumors in clinical practice has been primarily driven by the advent of next-generation sequencing (NGS). The term “NGS” includes several types of genomic sequencing methodologies, such as targeted ...
Read More »Implementation of an Open Source Software solution for Laboratory Information Management and automated RNA-seq data analysis
Large-scale cancer genomics initiatives and next-generation sequencing for transcriptome profiling allow for detailed molecular characterization of tumors, and provide opportunities for clinical tools to improve diagnosis, prognosis, and treatment decisions. Laboratory information, data management, and data sharing in large-scale genomics ...
Read More »Desperately Seq’ing RNA
from Genetic Engineering News by Vicki Glaser Next-Generation Sequencing Is Increasingly Making Headway in Clinical Medicine for Diagnostic and Prognostic Purposes It’s early days, but next-generation sequencing (NGS) is increasingly making headway in clinical medicine for diagnostic and prognostic purposes, for ...
Read More »PreAnalytiX GmbH, NuGEN Technologies and RUCDR Infinite Biologics partner to develop clinically validated RNA-Seq workflow for whole blood samples
Hombrechtikon, Switzerland, San Carlos, CA, Piscataway, NJ, January 27, 2015 — PreAnalytiX GmbH, NuGEN Technologies, Inc. and RUCDR Infinite Biologics (RUCDR), today announced a joint project to validate an end-to- end workflow for the reproducible collection and processing of whole ...
Read More »Early Bird Deadline Approaching – miRNA World 2014
It’s come around already. This is your last chance to access the best rate we have available for miRNA World 2014 to ensure you fully harness the clinical applications of miRNA’s. The world leaders of miRNA research are coming together ...
Read More »Recent Acquisition Strengthens Illumina’s Clinical Readiness
Illumina Acquires Myraqa, a Leading IVD and Companion Diagnostic Consulting Firm Acquisition Strengthens Illumina’s Clinical Readiness SAN DIEGO–(BUSINESS WIRE)–Jul. 16, 2014– Illumina, Inc. (NASDAQ:ILMN) today announced that it has acquired Myraqa, a regulatory and quality consulting firm specializing in IVDs, ...
Read More »